查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610206

器官移植診斷市場：按產品、技術和應用分類 - 2025-2030 年全球預測

Organ Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Technologies, Non-Molecular Technologies), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年器官移植診斷市值為42億美元，預計2024年將達到44.6億美元，複合年成長率為7.31%，到2030年將達到68.9億美元。

器官移植診斷市場包括診斷工具和測試的開發，以評估供體-受體的兼容性、監測移植健康狀況以及檢測可能的移植後排斥或感染疾病。這些診斷的需求源於確保器官移植成功、盡量減少併發症和延長移植物存活的迫切需求。主要應用包括移植前適宜性檢查、移植後監測和感染篩檢，最終用途包括醫院、移植中心和診斷實驗室。該市場的成長要素包括分子診斷的進步、導致器官衰竭的慢性疾病的流行以及器官移植手術的增加。此外，基因組學和蛋白​​質組學的技術創新正在實現更準確、更全面的診斷解決方案，擴大潛在的商機。利用這些機會的建議包括投資次世代定序技術的研究和開發以及擴大診斷組合以包括非侵入性檢測方法。然而，仍存在一些限制因素，例如診斷測試成本上升、低收入地區的准入有限以及阻礙產品核可的嚴格監管框架。應對這些挑戰需要策略聯盟、創新以降低成本以及倡導有利政策以提高市場滲透率。潛在的創新領域包括開發自動化診斷平台、預測長期移植結果的生物標記以及用於個人化移植醫學的人工智慧主導的資料分析工具。在持續的科學研究和技術進步的推動下，市場動態是充滿活力和競爭的。公司可以透過專注於與醫療機構的合作、擴展到醫療需求未滿足的新興市場以及保持敏捷性以適應監管變化而受益。透過專注於這些策略，相關人員可以增強其市場地位，並為改善全球移植診斷做出貢獻。

主要市場統計
基準年[2023] 42億美元
預測年份 [2024] 44.6億美元
預測年份 [2030] 68.9億美元
複合年成長率（%） 7.31%

市場動態：快速發展的器官移植診斷市場的關鍵市場洞察

供需的動態交互作用正在改變器官移植診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 肝功能衰竭、腎衰竭和心臟衰竭的發生率增加
    • 政府推動器官捐贈的努力
    • 精準醫學的興起改善器官移植診斷
  • 市場限制因素
    • 與診斷相關的技術限制
  • 市場機會
    • 開發下一代器官移植診斷學的研究與開發
    • 醫療旅遊在器官移植的潛力
  • 市場挑戰
    • 器官移植相關的倫理問題

波特五力：駕馭器官移植診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解器官移植診斷市場的外部影響

外部宏觀環境因素在塑造器官移植診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解器官移植診斷市場的競爭狀況

器官移植診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣器官移植診斷市場供應商績效評估

FPNV定位矩陣是評估器官移植診斷市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製器官移植診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對器官移植診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肝、腎和心臟衰竭的發生率增加
      • 政府推動器官捐贈的努力
      • 精準醫學的興起改善器官移植診斷
    • 抑制因素
      • 與診斷相關的技術限制
    • 機會
      • 促進下一代發展的器官移植診斷學的研究與開發
      • 醫療旅遊在器官移植的潛力
    • 任務
      • 器官移植相關的倫理問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 器官移植診斷市場：依報價

  • 裝置
  • 試劑/耗材
  • 軟體和服務

第7章器官移植診斷市場：依技術分類

  • 分子技術
  • 非分子技術

第8章器官移植診斷市場：依應用分類

  • 診斷應用
  • 調查申請

第9章北美及南美器官移植診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區器官移植診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲器官移植診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • BAG Diagnostics GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMAdvanced Diagnostics
  • Biomerieux SA.
  • Bruker Corporation
  • CareDx Inc.
  • F Hoffman La Roche Ltd.
  • GenDx by Eurobio Scientific
  • Genome Diagnostics BV
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Omixon Ltd.
  • Oncocyte Corporation
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Werfen
Product Code: MRR-5C6F41F5B031

The Organ Transplant Diagnostics Market was valued at USD 4.20 billion in 2023, expected to reach USD 4.46 billion in 2024, and is projected to grow at a CAGR of 7.31%, to USD 6.89 billion by 2030.

The organ transplant diagnostics market involves the development and application of diagnostic tools and tests to assess the compatibility of donors and recipients, monitor transplant health, and detect potential rejections or infections post-transplantation. The necessity for these diagnostics arises from the critical need to ensure successful organ transplantation outcomes, minimize complications, and prolong graft survival. The main application areas include pre-transplant compatibility testing, post-transplant monitoring, and infection screening, with significant end-use scope encompassing hospitals, transplant centers, and diagnostic laboratories. Influencing growth factors for this market include advancements in molecular diagnostics, increased prevalence of chronic diseases leading to organ failure, and a rise in organ transplant procedures. Additionally, technological innovations in genomics and proteomics are opening potential opportunities by enabling more precise and comprehensive diagnostic solutions. Recommendations to leverage these opportunities include investing in R&D for next-generation sequencing technologies and expanding diagnostic portfolios to include non-invasive testing methods. However, the market also faces limitations such as high costs of diagnostic tests, limited accessibility in low-income regions, and stringent regulatory frameworks that can impede swift product approvals. Addressing these challenges requires strategic collaborations, cost-reduction innovations, and advocacy for favorable policies to improve market penetration. Potential areas for innovation include the development of automated diagnostic platforms, biomarkers for predicting long-term transplant outcomes, and AI-driven data analysis tools for personalized transplant care. The nature of the organ transplant diagnostics market is dynamic and highly competitive, driven by continuous scientific research and technological advancements. Companies can benefit from focusing on collaborative efforts with healthcare institutions, expanding into emerging markets with unmet medical needs, and maintaining agility in adapting to regulatory changes. By emphasizing these strategies, stakeholders can enhance their market position and contribute to improved transplant diagnostic practices globally.

KEY MARKET STATISTICS
Base Year [2023] USD 4.20 billion
Estimated Year [2024] USD 4.46 billion
Forecast Year [2030] USD 6.89 billion
CAGR (%) 7.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplant Diagnostics Market

The Organ Transplant Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of liver, kidney, and heart failure
    • Government initiatives in promoting organ donation
    • Rise of precision medicine to improve organ transplant diagnostics
  • Market Restraints
    • Technical limitations associated with diagnostics
  • Market Opportunities
    • R&D to develop next generation organ transplant diagnostics
    • Potential of medical tourism in organ transplantation
  • Market Challenges
    • Ethical issues associated with organ transplant

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplant Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplant Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplant Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplant Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplant Diagnostics Market

A detailed market share analysis in the Organ Transplant Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplant Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplant Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organ Transplant Diagnostics Market

A strategic analysis of the Organ Transplant Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BAG Diagnostics GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMAdvanced Diagnostics, Biomerieux SA., Bruker Corporation, CareDx Inc., F Hoffman La Roche Ltd., GenDx by Eurobio Scientific, Genome Diagnostics B.V., Hologic Inc., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Omixon Ltd., Oncocyte Corporation, Qiagen N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., SQI Diagnostics, Thermo Fisher Scientific Inc., TransMedics, Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Organ Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Technology, market is studied across Molecular Technologies and Non-Molecular Technologies.
  • Based on Application, market is studied across Diagnostic Applications and Research Applications.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of liver, kidney, and heart failure
      • 5.1.1.2. Government initiatives in promoting organ donation
      • 5.1.1.3. Rise of precision medicine to improve organ transplant diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations associated with diagnostics
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D to develop next generation organ transplant diagnostics
      • 5.1.3.2. Potential of medical tourism in organ transplantation
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues associated with organ transplant
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organ Transplant Diagnostics Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Organ Transplant Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Molecular Technologies
  • 7.3. Non-Molecular Technologies

8. Organ Transplant Diagnostics Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
  • 8.3. Research Applications

9. Americas Organ Transplant Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Organ Transplant Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Organ Transplant Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BAG Diagnostics GmbH
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biogenuix Medsystems Pvt. Ltd
  • 6. BioMAdvanced Diagnostics
  • 7. Biomerieux SA.
  • 8. Bruker Corporation
  • 9. CareDx Inc.
  • 10. F Hoffman La Roche Ltd.
  • 11. GenDx by Eurobio Scientific
  • 12. Genome Diagnostics B.V.
  • 13. Hologic Inc.
  • 14. Illumina Inc.
  • 15. Laboratory Corporation of America Holdings
  • 16. Luminex Corporation
  • 17. Omixon Ltd.
  • 18. Oncocyte Corporation
  • 19. Qiagen N.V.
  • 20. Quest Diagnostics Incorporated
  • 21. Randox Laboratories Ltd.
  • 22. SQI Diagnostics
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransMedics, Inc.
  • 25. Werfen

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023